SCHEMBL875545

SCHEMBL875545

[C]OC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3804035 0.69
SCHEMBL1617488 0.67
SCHEMBL1617489 0.67
SCHEMBL9654751 0.65
Hydrochloric Acid SCHEMBL6438135 0.63
SCHEMBL1132992 0.63
SCHEMBL11652313 0.63
SCHEMBL1562061 0.60
SCHEMBL45125 0.59
SCHEMBL1296 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0250198-B1 BIS-AZOLYL COMPOUNDS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-02-28 EP claimed
EP-0287890-A1 Substituted pyrroles BAYER AG (DE) 1988-10-26 EP claimed
EP-2991993-B1 MORPHOLINYL ANTHRACYCLINE DERIVATIVES NERVIANO MEDICAL SCIENCES SRL (IT) 2018-06-06 EP disclosed
WO-2017205585-A1 COMBINATIONS AND USES TREATMENTS THEREOF VIIV HEALTHCARE COMPANY (US) 2017-11-30 WO disclosed
US-9828405-B2 Morpholinyl anthracycline derivatives NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2017-11-28 US disclosed
US-20170312290-A1 FUNCTIONALIZED MORPHOLINYL ANTHRACYCLINE DERIVATIVES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2017-11-02 US disclosed
EP-3215513-A1 FUNCTIONALIZED MORPHOLINYL ANTHRACYCLINE DERIVATIVES Nerviano Medical Sciences S.r.l. (IT) 2017-09-13 EP disclosed
WO-2016071418-A1 FUNCTIONALIZED MORPHOLINYL ANTHRACYCLINE DERIVATIVES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2016-05-12 WO disclosed
US-20160075730-A1 NEW MORPHOLINYL ANTHRACYCLINE DERIVATIVES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2016-03-17 US disclosed
EP-2991993-A1 NEW MORPHOLINYL ANTHRACYCLINE DERIVATIVES Nerviano Medical Sciences S.r.l. (IT) 2016-03-09 EP disclosed
US-9221928-B2 Fluorine-containing sulfonate resin, fluorine-containing N-sulfonyloxyimide resin, resist composition and pattern formation method CENTRAL GLASS COMPANY, LIMITED (JP) 2015-12-29 US disclosed
EP-0462009-A1 Cephalosporins having in position 3 a propenyl radical substituted by a quaternary ammonium, their process for preparation, their use as medicaments, compositions containing them and intermediates ROUSSEL UCLAF (FR) 1991-12-18 EP disclosed
EP-0352575-A2 Substituted annealed pyrroles BAYER AG (DE) 1990-01-31 EP disclosed
EP-0334147-A1 Disubstituted pyrroles BAYER AG (DE) 1989-09-27 EP disclosed
US-4867783-A CONTAINING A THREE OR FOUR MEMBER RING E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-09-19 US disclosed
EP-0330057-A2 Substituted pyrimidines BAYER AG (DE) 1989-08-30 EP disclosed
EP-0308283-A1 1,2,5,6-Tetrahydropyridine-3-carboxaldehyde oxime derivatives, process for their preparation, their use as pharmaceutical compounds and compositions containing them ROUSSEL-UCLAF (FR) 1989-03-22 EP disclosed
EP-0300278-A2 Process for the preparation of 2-substituted pyrroles BAYER AG (DE) 1989-01-25 EP disclosed
US-4616008-A LIPID-SOLUBLE CEPHALOSPORINS AND CYCLODEXTRINS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1986-10-07 US disclosed
EP-0163433-A2 Antibacterial solid composition for oral administation Takeda Chemical Industries, Ltd. (JP) 1985-12-04 EP disclosed